Pharmacotherapy: A Pathophysiologic Approach, ISBN:9780071478991
Quick Price Check:
From $81.26 Used From $108.98 New
Make selection below
Binding: Hardcover Release Date: June 2008 Edition: 7 List Price:$190.00
Average Customer Rating:
ISBN-13: 9780071478991 ISBN-10: 007147899X Author: Joseph DiPiro, Robert Talbert, Gary Yee, Gary Matzke, Barbara Wells, L. Michael Posey Publisher: McGraw-Hill Medical
Summaries and Customer Reviews are supplied by Amazon.com
Summary:
The seventh edition of the benchmark evidence-based pharmacotherapy text--now in full color!
Includes Online Learning Center--that features 11 additional chapters, learning objectives, interactive questions, and more!
A Doody's Core Title ESSENTIAL PURCHASE!
4 STAR DOODY'S REVIEW! "This book is, by far, one of the best in pharmacy. It is an exceptionally useful reference for both pharmacists and pharmacy students. It communicates a wealth of information that is well researched and referenced. The seventh edition is a much needed update."--Doody's Review Service
When it comes to helping you develop a mastery of evidence-based medicine for optimal patient outcomes, no book can match Pharmacotherapy: A Pathophysiologic Approach. Like the discipline it covers, the scope of this trusted resource goes beyond drug indications and dosages to include the initial selection, proper administration, and monitoring of drugs. Pharmacotherapy delivers everything you need to know to provide safe, effective drug therapy across the full range of therapeutic categories.
The book also delves into psychosocial issues that affect compliance--topics related to a patient's ability to understand and manage often-complex therapy--and lifestyle changes that may reduce the need for drug therapy or improve pharmacotherapeutic outcomes.
FEATURES
Key Concepts in each chapter
Critical Presentation boxes that summarize common disease signs and symptoms
Clinical Controversies boxes that examine complicated issues you face when providing drug therapy
Therapeutic recommendations in each disease-specific chapter
Evaluation of Therapeutic Outcomes Information in each disease-specific chapter containing key monitoring guidelines
NEW MATERIAL! including chapters on Pulmonary Hypertension, Disorders of Calcium and Phosphorous Homeostatis, and Multiple Myeloma
NEW! Expanded evidence-based recommendations
NEW! Extended coverage of the timely issue of palliative care and pain medicine
Customer Reviews:
Average Customer Rating:
which is best the hand book or the text?
Customer Rating:
I just received the pharmacotherapy handbook and haven't started yet,but i would like to know what's the difference between the hand book and the text.
Pharmacotherapy
Customer Rating:
Very easy to read, yet detailed book of pharmacotherapy. This book would be excellent for nurses, NPs, physician assistants, or medical students. I was very pleased with my investment in this book.
Great item!!!.
Customer Rating:
This was a great item in great condition, but I did not receive it as quickly as the add made it sound.
OK
Customer Rating:
The book was in good shape and shipped in great time. The only problem I have found is that there are 20 pages MISSING from the index! This really angers me because there was no indication of this in the description.
Great Pharm Text
Customer Rating:
Pharmacotherapy is the very best pharmacology text I've ever seen. The drugs are up to date as possible, the pathophysiology review is exceptionally helpful and the resources and studies addressed are excellent. While I'm a FNP student, not a pharmacist, I plan to continue to purchase updated versions for my practice in the future. It is an invaluable resource across health care disciplines. Special populations (ethnic groups, women, elderly, etc) are singled out at the end of each chapter while the discussion of comorbid conditions is thoughtful and realistic. Each chapter begins with key points that are also notated again within the chapter. The tables included help solidify overall characteristics of classes and compare individual drugs. Some providers may be more accustomed to trade names and find this difficult since they are generally not included except for some of the newest drugs.